Albireo Pharma, Inc.

( )
BIOD PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
SAVACassava Sciences, Inc. -0.20%50.780.0%$756.27m
GWPHGW Pharmaceuticals Plc -0.40%214.006.1%$392.07m
JAZZJazz Pharmaceuticals Plc 0.00%170.742.3%$191.25m
HZNPHorizon Therapeutics Plc -1.73%89.005.6%$191.05m
VRXValeant Pharmaceuticals International, Inc. 0.06%31.3014.1%$184.17m
BHCBausch Health Cos., Inc. 0.06%31.300.0%$141.73m
CTLTCatalent, Inc. 0.15%112.422.1%$113.99m
ICLRICON plc 0.00%184.444.2%$87.59m
ARGXargenx SE 0.00%339.470.0%$83.85m
TNXPTonix Pharmaceuticals Holding Corp. -3.28%1.180.2%$67.76m
ZYNEZynerba Pharmaceuticals, Inc. -2.47%4.356.0%$57.01m
PRGOPerrigo Co. Plc 0.10%40.826.8%$53.61m
AMRNAmarin Corp. Plc -0.72%6.901.5%$52.75m
UTHRUnited Therapeutics Corp. 0.00%168.8014.1%$46.29m
PBHPrestige Consumer Healthcare, Inc. 0.14%41.834.0%$43.24m

Company Profile

Albireo Pharma, Inc. engages in the development and commercialization of bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. It pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA.